Jackson Square Capital LLC Acquires 1,800 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jackson Square Capital LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 60.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,792 shares of the medical equipment provider's stock after buying an additional 1,800 shares during the quarter. Jackson Square Capital LLC's holdings in Intuitive Surgical were worth $2,501,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in ISRG. Mirador Capital Partners LP lifted its position in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after acquiring an additional 50 shares in the last quarter. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider's stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Consolidated Planning Corp boosted its stake in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after buying an additional 114,149 shares in the last quarter. Finally, Czech National Bank raised its position in shares of Intuitive Surgical by 6.9% in the fourth quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock valued at $40,309,000 after buying an additional 4,970 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.5 %

NASDAQ:ISRG traded up $8.56 during mid-day trading on Friday, reaching $592.64. 2,630,118 shares of the stock were exchanged, compared to its average volume of 1,158,623. The firm has a market capitalization of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $597.68. The business has a fifty day moving average price of $540.66 and a 200 day moving average price of $499.19.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Citigroup increased their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $554.17.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares of the company's stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the firm's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company's stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last 90 days. 0.80% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.